Standard BioTools Inc. (LAB)

Standard BioTools Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	174.43	106.34	97.95	128.85	131.39
Other Revenue	-	-	-	1.73	6.76
Revenue	174.43	106.34	97.95	130.58	138.14
Revenue Growth (YoY)	64.03%	8.57%	-24.99%	-5.47%	17.83%
Cost of Revenue	90.17	55.89	60.9	99.15	91.28
Gross Profit	84.26	50.45	37.05	31.43	46.87
Selling, General & Admin	156.61	87.54	102.29	98.89	97.9
Research & Development	62.41	25.95	33.86	-	-
Operating Expenses	219.02	113.49	136.14	98.89	97.9
Operating Income	-134.76	-63.04	-99.09	-67.46	-51.04
Interest Expense	-3.32	-4.57	-4.33	-3.82	-3.57
Interest & Investment Income	20.2	5.57	2.23	-	-
Other Non Operating Income (Expenses)	-5.17	1.39	-60.9	7.62	0.51
EBT Excluding Unusual Items	-123.05	-60.64	-162.09	-63.66	-54.1
Merger & Restructuring Charges	-40.48	-13.56	-13.59	-	-
Asset Writedown	-	-	-3.53	-	-
Other Unusual Items	25.21	-	-13.72	-	-
Pretax Income	-138.31	-74.2	-192.93	-63.66	-54.1
Income Tax Expense	0.57	0.45	-2.83	-4.42	-1.08
Net Income	-138.89	-74.66	-190.1	-59.24	-53.02
Preferred Dividends & Other Adjustments	46.01	-	-	-	-
Net Income to Common	-184.9	-74.66	-190.1	-59.24	-53.02
Shares Outstanding (Basic)	353	79	78	76	72
Shares Outstanding (Diluted)	353	79	78	76	72
Shares Change (YoY)	346.24%	1.09%	3.32%	5.19%	7.88%
EPS (Basic)	-0.52	-0.94	-2.43	-0.78	-0.74
EPS (Diluted)	-0.52	-0.94	-2.43	-0.78	-0.74
Free Cash Flow	-151.81	-46.12	-93.2	-57.33	-28.13
Free Cash Flow Per Share	-0.43	-0.58	-1.19	-0.76	-0.39
Gross Margin	48.31%	47.44%	37.83%	24.07%	33.92%
Operating Margin	-77.25%	-59.28%	-101.17%	-51.66%	-36.94%
Profit Margin	-106.00%	-70.20%	-194.08%	-45.36%	-38.38%
Free Cash Flow Margin	-87.03%	-43.37%	-95.15%	-43.90%	-20.37%
EBITDA	-117.9	-47.86	-84.06	-63.81	-47.02
EBITDA Margin	-67.59%	-45.01%	-85.82%	-48.86%	-34.04%
D&A For EBITDA	16.86	15.18	15.03	3.65	4.01
EBIT	-134.76	-63.04	-99.09	-67.46	-51.04
EBIT Margin	-77.25%	-59.28%	-101.17%	-51.66%	-36.94%
Revenue as Reported	174.43	106.34	97.95	130.58	138.14
Advertising Expenses	5.9	2	-	3.4	1.6

Updated Mar 11, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q